Accelerant Holdings (ARX) AI Stock Summary
Pending take-private announced
Updated
Snapshot
Accelerant is a fast-growing specialty insurance exchange that is technically unprofitable on paper due to large non-cash charges, but operationally it generates significant cash. Revenue surged 47% YoY to $879.5M, and the business produced $445M in operating cash flow and $404M in free cash flow. The balance sheet is extremely healthy with $2.51B in cash and only $121M in debt, providing ample cushion even with the headline net loss of $1.35B.
What's Happening Right Now
- Thu 13th Aug '26 · Acquisition: Accelerant agreed to be acquired by Thoma Bravo in an all-cash transaction valued at more than $4 billion, with shareholders receiving $20.25 per share.
- Tue 14th Jul '26 · Partnership: Accelerant entered a partnership with WoodStar to add over $220 million in underwriting capacity, advancing its fee-based model and expanding growth opportunities.
- Wed 1st Jul '26 · Partnership: The company launched the ARX Consortium to enhance its partnership with Lloyd's of London, backed by seven Lloyd's syndicates to support a diversified specialty risk portfolio.
Ownership
Institutions hold 0.0% of shares, while insiders hold 1.6%.
Bottom Line
The primary driver for this stock right now is the pending acquisition by Thoma Bravo. With a definitive agreement in place at $20.25 per share and the controlling shareholder voting in favor, the investment case is essentially a bet on the deal closing in the first half of 2027. The underlying business is growing fast and generating plenty of cash, which makes it an attractive target, but the trading range is likely to stay pinned to the offer price until then.